IHME Data

These Emergency Department (ED) health spending estimates are part of the Disease Expenditure Project (DEX) at IHME, which produced estimates for US spending on health care according to 3 types of payers: public insurance (including Medicare, Medicaid, and other government programs), private insurance, and out-of-pocket payments. This dataset contains ED spending estimates by aggregate health category, age group, sex, and payer for 2006 through 2016. The underlying data set used to generate estimates was the National Emergency Department Sample (NEDS); the DEX data pipeline was also leveraged to include government budgets, insurance claims, facility records, household surveys, and official US records from 2006 through 2016 to produce the results.

The Global Burden of Disease Study 2019 (GBD 2019), coordinated by the Institute for Health Metrics and Evaluation (IHME), estimated the burden of diseases, injuries, and risk factors for 204 countries and territories and selected subnational locations.

This dataset contains air pollution exposure estimates for ozone pollution, ambient particulate matter pollution, and household air pollution by year for 1990 to 2019. Population-weighted exposure summary files are provided for all air pollution risk factors, and gridded exposure files are provided for ozone and ambient particulate matter pollution. Files with GBD 2019 location hierarchies and ISO3 codes are also included. Estimates of disease burden attributable to air pollution risks are available through the GBD Results Tool.

For additional GBD results and resources, visit the GBD 2019 Data Resources page.

The Global Burden of Disease Study 2019 (GBD 2019), coordinated by the Institute for Health Metrics and Evaluation (IHME), estimated the burden of diseases, injuries, and risk factors for 204 countries and territories and selected subnational locations.

Estimates of 15 dietary risks and the burden attributable to these were produced for 1990-2019. Files available in this record include estimates of the daily intake of the 15 GBD food groups (either in grams or percent energy) by year, sex, and 5-year age groups for age 25 and up, with an aggregated 25+ age group. Estimates of disease burden attributable to dietary risks are available through the GBD Results Tool.

For additional GBD results and resources, visit the GBD 2019 Data Resources page.

This version of the Development Assistance for Health (DAH) Database includes estimates for 1990-2020, which are based on project databases, financial statements, annual reports, IRS 990s, and correspondence with agencies. The DAH Database enables comprehensive analysis of trends in international disbursements of grants and loans for health projects in low- and middle-income countries from key agencies. The data are disaggregated by source of funds, channel of funding, country and geographic region, health focus areas, and program areas. New in 2021: this release of the DAH Database incorporated estimates for COVID-19.

To better understand the data and how to use it, please refer to the IHME DAH Database 2019 User Guide.

Development Assistance for Health (DAH) on COVID-19 produced estimates for 2020, which are based on project databases, financial statements, annual reports, IRS 990s, and correspondence with agencies. The DAH Database enables comprehensive analysis of trends in international disbursements of grants and loans for COVID-19-related health projects in low- and middle-income countries from key agencies. The data are disaggregated by source of funds, channel of funding, country and geographic region, health focus areas, and program areas.

Research by the Global Burden of Disease Health Financing Collaborator Network produced projected health spending estimates for 2019-2050 for 204 countries and territories. The estimates cover total health spending, health spending disaggregated by source into three domestic financing source categories (government, out-of-pocket, and prepaid private), and development assistance for health (DAH). Retrospective health spending estimates for 1995-2018 and key covariates (including GDP per capita, total government spending, total fertility rate, and fraction of the population older than 65 years) were used to forecast GDP and health spending through 2050. Estimates are reported in constant 2020 US dollars, constant 2020 purchasing-power parity-adjusted (PPP) dollars, and as a percent of gross domestic product.

The Premise Malaria COVID-19 Health Services Disruption Survey 2021 is a follow-up series to the COVID-19 Health Services Disruption Survey 2020 series conducted in July 2020. These surveys were developed to assess the level of disruption to a range of health services resulting from the COVID-19 pandemic and subsequent government mandates and changes in behavior to mitigate the spread of the disease. Data generated from this survey is not intended to be used as an overall estimate of the level of health service delivery.

This survey was conducted in 51 countries using the smartphone-based Premise data collection platform. Respondents were 4,870 individual members of the general population in 20 African countries where malaria is endemic. The survey focused on the level of disruption to malaria prevention activities and malaria testing and treatment.

The Premise General Population COVID-19 Health Services Disruption Survey 2021 is a follow-up series to the COVID-19 Health Services Disruption Survey 2020 series conducted in July 2020. These surveys were developed to assess the level of disruption to a range of health services resulting from the COVID-19 pandemic and subsequent government mandates and changes in behavior to mitigate the spread of the disease. Data generated from this survey is not intended to be used as an overall estimate of the level of health service delivery.

This survey was conducted in 51 countries using the smartphone-based Premise data collection platform. Respondents were 18,649 individual members of the general population. The survey focused on the level of disruption to the provision of general health services, including visits to medical providers and access to medication.

The Premise Child Health COVID-19 Health Services Disruption Survey 2021 is a follow-up series to the COVID-19 Health Services Disruption Survey 2020 series conducted in July 2020. These surveys were developed to assess the level of disruption to a range of health services resulting from the COVID-19 pandemic and subsequent government mandates and changes in behavior to mitigate the spread of the disease. Data generated from this survey is not intended to be used as an overall estimate of the level of health service delivery.

This survey was conducted in 51 countries using the smartphone-based Premise data collection platform. Respondents were 7,383 individual members of the general population who served as caregiver to at least one child under the age of two years old. The survey focused on the level of disruption to vaccination and general health services for children under the age of two.

This dataset includes estimates of primary health care (PHC) expenditures, PHC expenditures in ambulatory settings, and PHC expenditures disaggregated by the System of Health Accounts (SHA) health care function category in low- and middle-income countries (LMICs) from 2000 through 2017. Three data sources were used to estimate PHC expenditures: recently published health expenditure estimates for each LMIC, which were constructed using 1662 country-reported National Health Accounts (NHAs); proprietary data from IQVIA to estimate expenditure of prescribed pharmaceuticals for PHC; and household surveys and costing estimates to estimate inpatient vaginal delivery expenditures.

Estimates were produced for environmental suitability of onchocerciasis presence at the 5x5 km-level in endemic countries across Africa. These estimates were produced using a boosted regression tree (BRT) analysis trained on reported onchocerciasis presence data from endemicity mapping surveys, surveillance during elimination programs, and other sources. The model was trained using data from 1974–2015; final estimates were produced using covariate values for 2013.

This dataset includes the following:

• GeoTIFF raster files for pixel-level estimates of environmental suitability for onchocerciasis presence.
• Code files used to generate the estimates.

Estimates of vaccination coverage for 11 childhood vaccines (first-dose bacillus Calmette-Guérin [BCG], first- and third-dose diphtheria-tetanus-pertussis [DTP1, DTP3], third-dose hepatitis B [HepB3], third-dose Haemophilus influenzae type b [Hib3], first- and second-dose measles [MCV1, MCV2], third-dose pneumococcal conjugate vaccine [PCV3], third-dose polio [Pol3], first-dose rubella-containing vaccine [RCV1], and complete rotavirus [RotaC, two or three doses]) were produced for 204 countries and territories between 1980 and 2019 as part of the Global Burden of Disease Study 2020, Release 1 (GBD 2020 R1). The estimation process primarily utilized household survey microdata, household survey report data in the absence of microdata, and estimates of country-reported coverage data.

This dataset includes the following:

• CSV files for national-level estimates of vaccine coverage, by vaccine
• Code files used to generate the estimates

Annual estimates were produced for HIV incidence and mortality among adults ages 15-49 at the 5x5 km-level for 44 countries in sub-Saharan Africa between 2000 and 2018. These estimates were produced using a geo-positioned dataset created from 717 sources representing antiretroviral treatment data in UNAIDS Spectrum country files, country-level reports from the Health Management Systems database, and PEPFAR data; HIV seroprevalence surveys; ANC Sentinel Surveillance data; covariate surveys; and country specific surveys.

This dataset includes the following:

• CSV files of aggregated incidence and mortality estimates for each country at zero, first and second administrative divisions
• Code files used to generate the estimates

The Global Burden of Disease Study 2019 (GBD 2019), coordinated by the Institute for Health Metrics and Evaluation (IHME), estimated the burden of diseases, injuries, and risk factors for 204 countries and territories and selected subnational locations.

Estimates of chewing tobacco use and the burden attributable to this risk factor were produced by sex, age group, and year for 204 countries and territories for 1990-2019. The files in this record include estimates of chewing tobacco use prevalence for people ages 15 and older by sex, age group, and year. Estimates of disease burden attributable to chewing tobacco use are available in the GBD Results Tool.

For additional GBD results and resources, visit the GBD 2019 Data Resources page.

Established in 2015 by the United Nations, the Sustainable Development Goals (SDGs) specify 17 universal goals for achieving "peace and prosperity" by reducing inequality, improving health and education, and more. Each goal contains a number of specific targets and indicators for measurement and is intended to be achieved by 2030. This dataset provides estimates on progress for indicator 5.2.1, the proportion of age-standardized prevalence of ever-partnered women ages 15 years and older who experienced physical or sexual violence by a current or former intimate partner in the last 12 months. Progress on this indicator is reported as index values (scaled 0 to 100) which cover 204 countries and territories from 1990 to 2019. The indicator is a component of SDG 5 (Achieve gender equality and empower all women and girls), target 5.2 (Eliminate all forms of violence against all women and girls in the public and private spheres, including trafficking and sexual and other types of exploitation).

These data are the product of a collaboration between the Institute for Health Metrics and Evaluation (IHME) and the Universidad Autónoma de Yucatán (UADY). The objective of the project was to improve maternal and child health and the quality of health information in the state of Yucatán, Mexico through assessing the knowledge of alarm signs, and access and utilization of health services, among caregivers of children under 5 years of age. This dataset includes the results of a household census and caregiver interviewer. The population under study includes caregivers of children under 5 in 8 municipalities in Yucatán. In total, data were collected from 2,996 households.

Annual estimates were produced for the HIV mortality rate and number of deaths due to HIV by sex and age group in the 0-80+ year range at the municipality level in six countries in Latin America: Brazil, Mexico, Guatemala, Costa Rica, Colombia, and Ecuador. The estimates cover from 2000 to 2017 in Brazil, Colombia, and Mexico; from 2009 to 2017 in Guatemala; from 2004 to 2014 in Ecuador; and from 2014 to 2016 in Costa Rica. Input data sources consisted of vital registration (VR) mortality data — anonymized individual-level records from all deaths reported in each country’s VR system occurring between the years of study.

This dataset includes the following:

• CSV files of estimates of the HIV mortality rate and the number of HIV deaths by age group and sex for each country at zero, first, and second administrative divisions
• Code files used to generate the estimates
• The shapefile used to inform the estimates

The Global Burden of Disease Study 2019 (GBD 2019), coordinated by the Institute for Health Metrics and Evaluation (IHME), estimated the burden of diseases, injuries, and risk factors for 204 countries and territories and selected subnational locations.

This dataset provides annual estimates for 1950–2019 for numbers of deaths, mortality rate, and probability of death by sex for 6 age groups under 5 years: 0–6 days (early neonatal), 7–27 days (late neonatal), 1–5 months, 6–11 months, 12–23 months, and 2–4 years. There were 7417 sources used to produce these estimates. These included 28,016 location-years of vital registration data, 481 surveys with complete birth histories, and 1081 sources on summary birth histories.

For additional GBD results and resources, visit the GBD 2019 Data Resources page.

The COVID-19 Health Services Disruption Survey 2020 is a series of surveys developed to assess the level of disruption to a range of health services resulting from the COVID-19 pandemic and subsequent government mandates and changes in behavior to mitigate the spread of the disease.

This survey was conducted by ORB International via telephone interview using nationally representative samples in Kenya, Nigeria, and South Africa. Respondents were individual members of the general population. Data were collected from 3,058 respondents. The survey focused on the level of disruption to the provision of general and reproductive health services, including access to medication and family planning.

The survey was developed specifically to assess the change in levels of service delivery prior to, and immediately following, the onset of the COVID-19 global pandemic. Data generated from this survey is not intended to be used as an overall estimate of the level of health service delivery.

The COVID-19 Health Services Disruption Survey 2020 is a series of surveys developed to assess the level of disruption to a range of health services resulting from the COVID-19 global pandemic and subsequent government mandates and changes in behavior to mitigate the spread of the disease.

This survey was conducted in 76 countries using the smartphone-based Premise data collection platform. Respondents were individual members of the general population ages 15-49 years who identified as women. Data were collected from 12,354 respondents. The survey focused on the level of disruption to family planning and reproductive health services and changes in risk of gender-based violence.

The survey was developed specifically to assess the change in levels of service delivery prior to, and immediately following, the onset of the COVID-19 global pandemic. Data generated from this survey is not intended to be used as an overall estimate of the level of health service delivery.

The COVID-19 Health Services Disruption Survey 2020 is a series of surveys developed to assess the level of disruption to a range of health services resulting from the COVID-19 global pandemic and subsequent government mandates and changes in behavior to mitigate the spread of the disease.

This survey was conducted in 76 countries using the smartphone-based Premise data collection platform. Respondents were individual members of the general population who served as caregiver to at least one child under the age of two years. Data were collected from 7,230 respondents. The survey focused on the level of disruption to the provision of vaccines and general health services for children under the age of two.

The survey was developed specifically to assess the change in levels of service delivery prior to, and immediately following, the onset of the COVID-19 global pandemic. Data generated from this survey is not intended to be used as an overall estimate of the level of health service delivery.

These data were collected and compiled as part of the Improving Methods to Measure Comparable Mortality by Cause (IMMCMC) project, funded by Australia's National Health and Medical Research Council (NHMRC). Verbal autopsies (VAs) were conducted between 2011 and 2014 in three sites: Bohol, Philippines; Chandpur and Comila Districts, Bangladesh; and Central and Eastern Highlands Provinces, Papua New Guinea. Diagnostic criteria and cause lists similar to those employed in the Population Health Metrics Research Consortium (PHMRC) study were used to identify gold standard (GS) deaths. This study added 3512 deaths (2491 adults, 320 children, and 701 neonates) to the GS VA database created from the PHMRC study. This dataset contains the combined PHMRC and IMMCMC data for an updated GS VA database.

The Global Burden of Disease Study 2019 (GBD 2019), coordinated by the Institute for Health Metrics and Evaluation (IHME), estimated the burden of diseases, injuries, and risk factors for 204 countries and territories and selected subnational locations.

Annual estimates for incidence, prevalence, mortality, years of life lost (YLLs), years lived with disability (YLDs), and disability-adjusted life years (DALYs) due to 369 diseases and injuries are available from the GBD Results Tool. Estimates are available by age and sex for 1990-2019. Select tables published in The Lancet in October 2020 in "Global burden of 369 diseases and injuries, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019" are also available for download via the “Files” tab above.

For additional GBD results and resources, visit the GBD 2019 Data Resources page.

The Global Burden of Disease Study 2019 (GBD 2019), coordinated by the Institute for Health Metrics and Evaluation (IHME), estimated the burden of diseases, injuries, and risk factors for 204 countries and territories and selected subnational locations.

This dataset provides estimates for relative risks due to exposure to particulate matter for ischemic heart disease, stroke, chronic obstructive pulmonary disease, lung cancer, acute lower respiratory infection, type 2 diabetes mellitus, as well as birthweight and gestational age shifts, low birthweight (<2500g), and pre-term births (<37 weeks). The input data used to create the estimates are also provided. These splines are generated using the MR-BRT meta-regression tool and input data from epidemiologic studies of exposure to ambient air pollution, household air pollution from the use of solid fuels, and secondhand tobacco smoke.